Application of artificial intelligence and robots in surgery: Three stocks that are expected to lead the next medical revolution

Large language models (LLMs) are expected to outperform humans in medical diagnosis by April 2025, with studies showing classification accuracy ranging from 66.5% to 98%. Integration with surgical robots is advancing, as reflected by companies such as Accuray Inc. (ARAY). The company offers a stereotactic radio [surgical] system that shows up 264% upside potential despite recent revenue declines. Siemens Healthcare (SMMNY) has a 28% upside, leading the field of artificial intelligence medical imaging and endovascular robotics, with reported revenue of €5.6 billion. Intuitive Surgery (ISRG) shares rose 26.6%, with its Da Vinci system dominating the robot-assisted [surgery] field, with revenue reaching $2.44 billion in the second quarter and net revenue growth of 24.5%. The global surgical robot market is expected to grow at a CAGR of 9.42% to reach USD 7.42 billion by 2030.